Salicylic Acid Market Poised for Remarkable Growth at 7.1% CAGR by 2035 | Future Market Insights, Inc.
GlobeNewswire· 2025-01-09 09:45
Increase in demand for preserved food & beverages and several personal care products drives the growth of the global premium salicylic acid market. On the other hand, consumer awareness about certain harmful effects of the acid hampers the growth to some extent. However, high adoption of premium salicylic acid in pharmaceuticals and cosmetics and increase in demand for aspirin drugs are expected to create lucrative opportunities in the industryNEWARK, Del, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The global Salicy ...
Growth Trends in the $1.84 Billion DDI Market, 2032: Revenue and % Share by Component, Deployment Mode, Organisation Size, Application, Industry Vertical and Region
GlobeNewswire· 2025-01-09 09:37
DDI Solutions Propel Cloud, IoT, and 5G Network Automation with Zero Trust Security DDI Market DDI Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "DDI Market Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The market is analyzed by component, deployment mode, organisation size, application, industry vertical, and region.According to this report, the global DDI market value reached USD 689.26 million in 2023. Aided by the growing adoption of advanced network technolo ...
Single-use Bioprocessing Probes and Sensors Market Forecast to Reach $10.95 Billion by 2034 - pH Sensors Dominate Bioprocessing Market, While Oxygen Sensors Lead Rapid Growth in Precision Biologics Monitoring
GlobeNewswire· 2025-01-09 09:34
Innovations in Single-Use Sensors Fuel Growth in Precision and Scalability Across the Industry Global Single-use Bioprocessing Probes and Sensors Market Global Single-use Bioprocessing Probes and Sensors Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Single-use Bioprocessing Probes and Sensors Market by Type, by Workflow, by End-User, and by Region" report has been added to ResearchAndMarkets.com's offering. This comprehensive research report focuses on the global and regional market size and for ...
Minisforum to Unveil Groundbreaking Innovations at CES 2025: AI X1 Mini PC and N5 Pro NAS
GlobeNewswire· 2025-01-09 09:32
Product Announcements - Minisforum will unveil two new products at CES 2025: the AI X1 Mini PC and the N5 Pro NAS, showcasing the company's commitment to technological innovation [1] - The AI X1 Mini PC features the AMD Ryzen™ AI 9 HX 370 processor, known for its low power efficiency, and is designed for seamless AI integration [2] - The N5 Pro NAS offers a maximum storage capacity of 144TB, with five SATA bays supporting up to 22TB each, an M.2 NVMe SSD up to 4TB, and two U.2 NVMe SSDs up to 15TB each [6] Product Features - The AI X1 Mini PC is equipped with the AMD Radeon™ 890M, enabling 60+ FPS 3A gaming and high-quality visuals [5] - The N5 Pro NAS includes two high-speed network ports (10GbE and 5GbE) capable of achieving data speeds up to 1250MB/s, ideal for transferring large files or 4K videos [6] - Advanced ECC RAM in the N5 Pro NAS ensures data integrity by automatically detecting and correcting memory errors, enhancing reliability for mission-critical storage [6] CES 2025 Participation - Minisforum will showcase the AI X1 Mini PC and N5 Pro NAS at CES 2025, with live demonstrations at Booth 30157 in the LVCC South Hall 1 [4] - The event will take place from January 7-10, 2025, providing an exclusive opportunity to explore the advanced capabilities of these products [4] Company Overview - Minisforum specializes in creating innovative, high-performance computing solutions, including AI-driven mini PCs and robust storage systems, designed to meet diverse user needs [4]
Ski Gear and Equipment Market to hit USD 2.45 billion by 2032, says Global Market Insights Inc.
GlobeNewswire· 2025-01-09 09:30
Ski gear and equipment industry is projected to witness a CAGR of 3.6% during the period 2024-2032. This growth can be attributed to rising popularity of winter sports.Selbyville, Delaware, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Ski Gear and Equipment Market size valued at USD 1.79 billion in 2023, is projected to grow at 3.6% CAGR from 2024 to 2032. With winter sports, particularly skiing, gaining popularity worldwide, the demand for quality ski gear is rising. Request for a sample of this research report @ htt ...
Medical Device Packaging Market to Surpass Valuation of US$ 59.82 Billion By 2033 | Astute Analytica
GlobeNewswire· 2025-01-09 09:30
As medical devices become more intricate, packaging evolves with high-barrier films, specialized inert gases, and nano-coatings. Global R&D centers expand capacity for sterilization innovation, motivated by growing patient needs and clinical safety standards. Worldwide, intelligent packaging solutions continue to flourish.New Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The global medical device packaging market is projected to grow from US$ 32.87 billion in 2024 to US$ 59.82 billion by 2033, at a CAGR of 6.88% ...
Growth Trends in the Pediatric Cancer Biomarkers Market, 2024-2034 - Roche, Thermo Fisher Scientific, Illumina, QIAGEN, and Bio-Rad Laboratories Dominate the Competition
GlobeNewswire· 2025-01-09 09:28
Global Pediatric Cancer Biomarkers Market Global Pediatric Cancer Biomarkers Market Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pediatric Cancer Biomarkers Market by Indication, Biomarker, End User, and Region" report has been added to ResearchAndMarkets.com's offering. This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.The global pediatric cancer biomarkers market size was estimated to be USD 0.888 billion in 2023 and is expected to rea ...
Openreach chooses Nokia to build open-access fiber network to connect millions to faster broadband
GlobeNewswire· 2025-01-09 09:28
Press ReleaseOpenreach chooses Nokia to build open-access fiber network to connect millions to faster broadband Nokia building open access platform to accelerate fiber broadband services for millions of UK homes and businesses.Nokia’s intent-based model enables Openreach to reduce operations support systems (OSS) complexity by 85%. Nokia’s domain controllers allow Openreach to fully automate and simplify network operations, driving scalability and operational efficiency throughout its network. 9 January 202 ...
PARP Inhibitor Biomarkers Market Review 2024 and Forecast 2025-2035: Breast Cancer Applications Lead in Revenue, While Ovarian Cancer Emerges as the Fastest-Growing Opportunity
GlobeNewswire· 2025-01-09 09:26
Market Overview - The global PARP inhibitor biomarkers market was valued at USD 0.985 billion in 2024 and is projected to reach USD 2.43 billion by 2035, growing at a CAGR of 8.57% during the forecast period (2025-2035) [3] - The market growth is driven by rising cancer rates, increasing adoption of precision medicine, advancements in genomic research, more FDA approvals, expanding indications, partnerships, collaborations, and government funding [3] Key Players - The report includes detailed profiles of major industry players such as AstraZeneca, GlaxoSmithKline (GSK), Pfizer, Inc., Merck & Co., Inc., Clovis Oncology, Novartis International AG, Roche Holding AG, and Bristol-Myers Squibb [1] Market Segmentation by Product - The kits segment accounted for the highest revenue in 2024 due to the widespread adoption of ready-to-use diagnostic kits in clinical settings [5] - The assays segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing demand for high-precision testing methods and advancements in assay technologies [5] Market Segmentation by Service - The BRCA 1 & 2 testing segment generated the highest revenue in 2024, attributed to the high prevalence of BRCA mutations in breast and ovarian cancers [6] - The HRD testing segment is predicted to grow at the fastest CAGR, reflecting the focus on identifying broader patient populations beyond BRCA mutations [6] Market Segmentation by Application - The breast cancer segment led the market in revenue in 2024, driven by the high incidence of breast cancer and growing adoption of PARP inhibitors for BRCA-mutated patients [7] - The ovarian cancer segment is expected to grow at the fastest CAGR, supported by expanding use of PARP inhibitors and increasing research into biomarkers [7] Market Segmentation by End-User - Hospitals and clinics accounted for the highest revenue in 2024, due to high patient volume and preference for hospitals for cancer diagnosis and treatment services [8] - Diagnostic laboratories are predicted to grow at the fastest CAGR, driven by the outsourcing of specialized biomarker testing services and demand for high-throughput diagnostics [8] Regional Analysis - North America is anticipated to hold the highest revenue share during the forecast period, supported by well-established healthcare infrastructure, high adoption of precision medicine, and presence of leading pharmaceutical companies [9] - The Asia Pacific region is expected to grow at the fastest CAGR, driven by rapidly expanding healthcare infrastructure, increasing awareness of cancer diagnostics, rising healthcare spending, and a growing patient population [9] Technological Advancements - The introduction of the PARP Activity Screening and Inhibitor Testing Assay (PASTA) in January 2023 has advanced the understanding of PARP-related therapies and improved treatment precision [5] - Genome-wide CRISPR knockout screens have identified novel markers of prostate cancer resistance to PARP inhibitors, such as the MMS22L gene [9]
Correction: Final terms for bonds to be listed 10th January 2025
GlobeNewswire· 2025-01-09 09:22
To Nasdaq Copenhagen A/S 9th January 2025 Announcement no. 3/2025CORRECTION: ISIN DK0009416893 is a Realkreditobligation (RO)Final terms for bonds to be listed 10th January 2025On 10th January 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage B ...